$13.64
-0.64-4.48%
In chiusura: Nov 19, 4:00 PM EST
$13.61
-0.03-0.22%
Pre-mercato: 5:16 AM EST
Comments
Loading...
EyePoint Pharmaceuticals Rapporto sugli interessi allo scoperto
EYPTNASDAQ
Report sulle vendite allo scoperto
Il short interest su EyePoint Pharmaceuticals Inc (NASDAQ:EYPT) è diminuito durante l'ultimo periodo di rilevazione, aumentando da 8.13M a 7.56M. Questo rappresenta il 10.9% delle azioni disponibili pubblicamente dell'azienda.
Sulla base del volume medio recente di 1.29M azioni scambiate al giorno, ci vorrebbero 5.85 giorno(i) per chiudere le posizioni di questo interesse a breve senza spingere fortemente al rialzo il titolo.
Vendite allo scoperto
7.56M
Vendite allo scoperto %
10.9%
Giorni di copertura
5.85
Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
EYPT | EyePoint Pharmaceuticals, Inc. | 10/31/2025 | 11/11/2025 | 10.90% | 69,332,536 | 7,558,136 | 1,292,705 | 5.85 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 10/15/2025 | 10/24/2025 | 11.72% | 69,332,536 | 8,125,396 | 1,498,424 | 5.42 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 09/30/2025 | 10/09/2025 | 13.92% | 57,506,692 | 8,002,454 | 1,091,310 | 7.33 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 09/15/2025 | 09/24/2025 | 15.46% | 57,506,692 | 8,888,073 | 961,782 | 9.24 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 08/29/2025 | 09/10/2025 | 14.70% | 57,506,692 | 8,450,737 | 618,848 | 13.66 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 08/15/2025 | 08/26/2025 | 13.36% | 57,506,692 | 7,685,446 | 750,807 | 10.24 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 07/31/2025 | 08/11/2025 | 12.02% | 57,506,692 | 6,910,406 | 536,543 | 12.88 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 07/15/2025 | 07/24/2025 | 11.70% | 57,391,003 | 6,715,395 | 755,360 | 8.89 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 06/30/2025 | 07/10/2025 | 12.08% | 57,391,003 | 6,934,144 | 853,954 | 8.12 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 06/13/2025 | 06/25/2025 | 11.74% | 57,391,003 | 6,738,690 | 813,450 | 8.28 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 05/30/2025 | 06/10/2025 | 12.49% | 57,391,003 | 7,167,676 | 1,093,975 | 6.55 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 05/15/2025 | 05/27/2025 | 12.56% | 57,391,003 | 7,206,930 | 616,327 | 11.69 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 04/30/2025 | 05/09/2025 | 17.55% | 57,390,624 | 10,070,848 | 646,574 | 15.58 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 04/15/2025 | 04/25/2025 | 19.43% | 60,859,716 | 11,823,252 | 1,051,347 | 11.25 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 03/31/2025 | 04/09/2025 | 17.96% | 60,859,716 | 10,928,768 | 706,077 | 15.48 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 03/14/2025 | 03/25/2025 | 17.79% | 60,859,716 | 10,828,642 | 835,810 | 12.96 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 02/28/2025 | 03/11/2025 | 17.64% | 60,859,716 | 10,734,271 | 798,205 | 13.45 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 02/14/2025 | 02/26/2025 | 18.36% | 60,381,987 | 11,085,338 | 1,143,022 | 9.7 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 01/31/2025 | 02/11/2025 | 17.76% | 60,381,987 | 10,724,031 | 590,407 | 18.16 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 01/15/2025 | 01/27/2025 | 17.52% | 60,381,987 | 10,581,127 | 842,870 | 12.55 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 12/31/2024 | 01/10/2025 | 17.12% | 60,381,987 | 10,336,822 | 925,498 | 11.17 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 12/13/2024 | 12/24/2024 | 15.59% | 60,381,987 | 9,412,339 | 872,836 | 10.78 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 11/29/2024 | 12/10/2024 | 15.31% | 60,381,987 | 9,246,846 | 1,084,664 | 8.53 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 11/15/2024 | 11/26/2024 | 16.36% | 60,381,987 | 9,876,306 | 700,506 | 14.1 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 10/31/2024 | 11/11/2024 | 16.03% | 60,381,987 | 9,680,960 | 1,332,618 | 7.26 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 10/15/2024 | 10/24/2024 | 20.09% | 45,649,166 | 9,171,397 | 519,913 | 17.64 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 09/30/2024 | 10/09/2024 | 19.56% | 45,649,166 | 8,929,577 | 627,912 | 14.22 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 09/13/2024 | 09/24/2024 | 19.94% | 45,649,166 | 9,101,038 | 594,592 | 15.31 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 08/30/2024 | 09/11/2024 | 19.96% | 45,649,166 | 9,111,785 | 451,868 | 20.16 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 08/15/2024 | 08/26/2024 | 20.77% | 45,649,166 | 9,479,305 | 744,036 | 12.74 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 07/31/2024 | 08/09/2024 | 20.91% | 45,649,166 | 9,546,661 | 683,440 | 13.97 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 07/15/2024 | 07/24/2024 | 22.80% | 44,215,331 | 10,082,910 | 861,744 | 11.7 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 06/28/2024 | 07/10/2024 | 21.78% | 44,215,331 | 9,629,305 | 955,888 | 10.07 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 06/14/2024 | 06/26/2024 | 20.32% | 44,215,331 | 8,983,568 | 1,000,666 | 8.98 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 05/31/2024 | 06/11/2024 | 17.51% | 44,215,331 | 7,743,543 | 856,247 | 9.04 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 05/15/2024 | 05/24/2024 | 18.40% | 44,215,331 | 8,134,745 | 2,130,489 | 3.82 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 04/30/2024 | 05/09/2024 | 14.94% | 44,215,331 | 6,604,050 | 1,246,697 | 5.3 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 04/15/2024 | 04/24/2024 | 14.78% | 44,215,104 | 6,536,042 | 562,026 | 11.63 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 03/28/2024 | 04/09/2024 | 18.73% | 36,543,472 | 6,845,404 | 666,987 | 10.26 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 03/15/2024 | 03/26/2024 | 18.00% | 36,543,472 | 6,579,352 | 1,193,166 | 5.51 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 02/29/2024 | 03/11/2024 | 15.66% | 36,543,472 | 5,724,135 | 1,079,102 | 5.3 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 02/15/2024 | 02/27/2024 | 13.36% | 35,551,523 | 4,749,694 | 1,053,768 | 4.51 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 01/31/2024 | 02/09/2024 | 14.44% | 35,551,523 | 5,135,381 | 986,415 | 5.21 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 01/12/2024 | 01/24/2024 | 14.64% | 35,551,523 | 5,204,915 | 1,064,454 | 4.89 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 12/29/2023 | 01/10/2024 | 14.99% | 35,551,523 | 5,330,028 | 1,134,424 | 4.7 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 12/15/2023 | 12/27/2023 | 13.36% | 35,551,523 | 4,750,651 | 4,642,372 | 1.02 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 11/30/2023 | 12/11/2023 | 19.72% | 35,551,523 | 7,010,685 | 689,582 | 10.17 | |
EYPT | EyePoint Pharmaceuticals, Inc. | 11/15/2023 | 11/27/2023 | 24.71% | 22,022,112 | 5,440,695 | 525,745 | 10.35 |
In cerca di azioni più vendute allo scoperto?